Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Unspecified transplanted organ and tissue infection
Summary
Unspecified transplanted organ and tissue infection refers to an infectious process affecting a transplanted organ or tissue where the specific type of infection is not documented. These infections can arise from bacterial, viral, or fungal sources and may impact graft function or patient outcomes. Management requires prompt identification and targeted antimicrobial therapy to prevent complications.
Causes
Infections may result from bacterial, viral, or fungal pathogens, often introduced during transplantation or through postoperative exposure. Immunosuppressive therapy, which is standard in transplant recipients, increases susceptibility to infections. Surgical site contamination or donor-derived infections can also contribute to the development of these infections.
Risk Factors
- Immunosuppressive therapy (e.g., corticosteroids, calcineurin inhibitors)
- Prolonged hospitalization or intensive care unit stay
- Pre-existing infections or comorbidities (e.g., diabetes, renal failure)
- Surgical complications (e.g., anastomotic leaks, poor wound healing)
- Mismatched donor-recipient compatibility or prior rejection episodes
Symptoms
- Fever or chills
- Pain or tenderness at the transplant site
- Swelling, redness, or drainage from the surgical area
- Decreased organ function (e.g., elevated creatinine, jaundice)
- Fatigue or malaise
- Unexplained weight loss
Diagnosis
Diagnosis involves clinical evaluation, imaging studies (e.g., ultrasound, CT), and laboratory tests to assess organ function and detect infection. Blood cultures, tissue biopsies, or serologic testing may identify the causative organism. Imaging helps evaluate graft integrity and rule out abscesses or fluid collections.
Treatment Options
Treatment typically includes targeted antimicrobial therapy based on culture results, with adjustments for drug interactions or organ dysfunction. Supportive care, such as hydration or organ function support, may be necessary. In severe cases, surgical intervention (e.g., drainage, graft removal) may be required.
Prognosis and Follow-Up
Prognosis depends on the type of infection, timing (early vs. late post-transplant), and response to treatment. Early detection and appropriate therapy improve outcomes. Follow-up includes monitoring for recurrence, graft function, and immunosuppression adjustments. Long-term surveillance is essential to prevent complications.
Complications
- Graft failure or rejection
- Sepsis or systemic infection
- Organ dysfunction (e.g., renal, hepatic)
- Surgical site complications (e.g., abscess, dehiscence)
- Increased mortality risk
Lifestyle & Prevention
- Adhere to prescribed immunosuppressive regimens
- Practice good hygiene (e.g., handwashing, wound care)
- Avoid exposure to infectious agents (e.g., sick contacts, contaminated environments)
- Report early signs of infection (e.g., fever, pain) promptly
- Follow post-transplant care guidelines for diet and activity
When to Seek Professional Help
Seek immediate medical attention for:
- Persistent fever or chills
- Worsening pain, swelling, or redness at the transplant site
- Changes in organ function (e.g., reduced urine output, jaundice)
- Signs of systemic infection (e.g., confusion, hypotension)
Tips for Medical Coders
Document the type of transplanted organ or tissue (if known) and any associated details (e.g., timing, causative organism) to support coding accuracy. Use this code when the infection is unspecified or when documentation lacks specificity. Ensure alignment with clinical notes to reflect the condition accurately.
Medical Policies and Guidelines
Related policies from health plans
T86.93 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.